Similar, the modification of cytokines including plasminogen activator inhibitor 1, adiponectin or interleukin 6, have been described in the association with NAFLD, and more strongly with non-alcoholic steatohepatitis [33]. This evidence concerns the gene SERPINE1 and metabolic dysfunction-associated steatohepatitis.